Elucidation of neuronal activity in mouse models of temporomandibular joint injury and inflammation by in vivo GCaMP Ca2+ imaging of intact trigeminal ganglion neurons
Open Access
- 1 October 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 165 (12) , 2794-2803
Abstract
Patients with temporomandibular disorders (TMDs) typically experience facial pain and discomfort or tenderness in the temporomandibular joint (TMJ), causing disability in daily life. Unfortunately, existing treatments for TMD are not always effective, creating a need for more advanced, mechanism-based therapies. In this study, we used in vivo GCaMP3 Ca 2+ imaging of intact trigeminal ganglia (TG) to characterize functional activity of the TG neurons in vivo, specifically in mouse models of TMJ injury and inflammation. This system allows us to observe neuronal activity in intact anatomical, physiological, and clinical conditions and to assess neuronal function and response to various stimuli. We observed a significant increase in spontaneously and transiently activated neurons responding to mechanical, thermal, and chemical stimuli in the TG of mice with TMJ injection of complete Freund adjuvant or with forced mouth opening (FMO). An inhibitor of the calcitonin gene–related peptide receptor significantly attenuated FMO-induced facial hypersensitivity. In addition, we confirmed the attenuating effect of calcitonin gene–related peptide antagonist on FMO-induced sensitization by in vivo GCaMP3 Ca 2+ imaging of intact TG. Our results contribute to unraveling the role and activity of TG neurons in the TMJ pain, bringing us closer to understanding the pathophysiological processes underlying TMJ pain after TMJ injury. Our study also illustrates the utility of in vivo GCaMP3 Ca 2+ imaging of intact TG for studies aimed at developing more targeted and effective treatments for TMJ pain.Keywords
Funding Information
- NIDCR (DE031477)
- NINDS (NS128574)
- NIDCR (T32DE014318)
This publication has 45 references indexed in Scilit:
- An Update on Temporomandibular Disorders (TMDs) and HeadacheCurrent Neurology and Neuroscience Reports, 2023
- Sensory Neuron-TRPV4 Modulates Temporomandibular Disorder Pain Via CGRP in MiceThe Journal of Pain, 2022
- Transient Receptor Potential (TRP) Ion Channels in Orofacial PainMolecular Neurobiology, 2021
- Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediatorsJournal of Neural Transmission, 2020
- A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: Role of CGRP in orofacial painExperimental Neurology, 2015
- Mutual effect between neuropeptides and inflammatory cytokines in neurogenic SMSCs of human temporomandibular jointCurrent Medical Science, 2014
- Orcinol glucoside produces antidepressant effects by blocking the behavioural and neuronal deficits caused by chronic stressEuropean Neuropsychopharmacology, 2014
- Peripheral and central mechanisms of orofacial inflammatory pain2011
- Cellular and Molecular Mechanisms of PainCell, 2009
- Vascular endothelial growth factor plays an important autocrine/paracrine role in the progression of osteoarthritisHistochemistry and Cell Biology, 2005